Literature DB >> 2621173

The activity of amoxycillin/clavulanic acid against Pseudomonas pseudomallei.

D A Dance1, V Wuthiekanun, W Chaowagul, N J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2621173     DOI： 10.1093/jac/24.6.1012

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

Review 1.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

3.  Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.

Authors:  Allen C Cheng; Wirongrong Chierakul; Wipada Chaowagul; Ploenchan Chetchotisakd; Direk Limmathurotsakul; David A B Dance; Sharon J Peacock; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

Review 4.  Treatment and prophylaxis of melioidosis.

Authors:  David Dance
Journal:  Int J Antimicrob Agents       Date:  2014-02-03       Impact factor: 5.283

5.  Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010.

Authors:  Rebecca Lipsitz; Susan Garges; Rosemarie Aurigemma; Prasith Baccam; David D Blaney; Allen C Cheng; Bart J Currie; David Dance; Jay E Gee; Joseph Larsen; Direk Limmathurotsakul; Meredith G Morrow; Robert Norton; Elizabeth O'Mara; Sharon J Peacock; Nicki Pesik; L Paige Rogers; Herbert P Schweizer; Ivo Steinmetz; Gladys Tan; Patrick Tan; W Joost Wiersinga; Vanaporn Wuthiekanun; Theresa L Smith
Journal:  Emerg Infect Dis       Date:  2012-12       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.